Evidence map›Paper›PMID 33258451›Full record

ArticleeLife2020

Small molecule cognitive enhancer reverses age-related memory decline in mice.

Karen Krukowski, Amber Nolan, Elma S Frias, Morgane Boone, Gonzalo Ureta, Katherine Grue, Maria-Serena Paladini, Edward Elizarraras, Luz Delgado, Sebastian Bernales and 2 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 2 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 2 syntheses or guidelines pooled it, 167 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Distinct cell type-specific mechanisms underlie cognitive dysfunction during persistent integrated stress response activation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Progenitor Resilience and the Early Onset of Chronic Lung Diseases: NHLBI workshop report.American journal of respiratory cell and molecular biology · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. The Yin-Yang of Stress and Senescence: Integrated Stress Response and SASP Crosstalk in Stem Cell Fate, Regeneration, and Disease.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Karen KrukowskiDepartment of Physical Therapy and Rehabilitation Science, University of California at San Francisco, San Francisco, United States.ORCID 0000-0003-0281-8917
Amber Nolan *Brain and Spinal Injury Center, University of California at San Francisco, San Francisco, United States.
Elma S Frias *Department of Physical Therapy and Rehabilitation Science, University of California at San Francisco, San Francisco, United States.
Morgane Boone *Biochemistry and Biophysics, University of California at San Francisco, San Francisco, United States.ORCID 0000-0002-7807-5542
Gonzalo UretaFundación Ciencia & Vida, Santiago, Chile.
Katherine GrueDepartment of Physical Therapy and Rehabilitation Science, University of California at San Francisco, San Francisco, United States.
Maria-Serena PaladiniDepartment of Physical Therapy and Rehabilitation Science, University of California at San Francisco, San Francisco, United States.
Edward ElizarrarasDepartment of Physical Therapy and Rehabilitation Science, University of California at San Francisco, San Francisco, United States.
Luz DelgadoFundación Ciencia & Vida, Santiago, Chile.
Sebastian BernalesFundación Ciencia & Vida, Santiago, Chile.
Peter WalterBiochemistry and Biophysics, University of California at San Francisco, San Francisco, United States.ORCID 0000-0002-6849-708X
Susanna RosiDepartment of Physical Therapy and Rehabilitation Science, University of California at San Francisco, San Francisco, United States.ORCID 0000-0002-9269-3638
University of California, San Francisco · USFundación Ciencia and Vida · CLHoward Hughes Medical Institute · US

Funding

Maximizing Opportunities for Research Excellence - Evaluation Training SupplementR25GM056847 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUNCAN, D'ANNE S., SELLO, JASON K · 1998 to 2023
$14.1M
NRSA Training CoreTL1TR001871 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KANAYA, ALKA M., SOMSOUK, MA · 2016 to 2025
$10.1M
Aging exacerbates trauma-induced immune pathways and neuronal dysfunctionR01AG056770 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSI, SUSANNA · 2017 to 2021
$1.7M
Cortical Somatostatin Interneuron Dysfunction after Trauma: Role in Cognitive FlexibilityK08NS114170 · NINDS · UNIVERSITY OF WASHINGTON · PI NOLAN, AMBER L · 2019 to 2023
$1.0M
Impact of aging on immune activation and cognitive decline after traumatic brain injuryF32AG054126 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRUKOWSKI, KAREN · 2017 to 2018
$128k
NCATS NIH HHS TL1 TR001871NIA NIH HHS F32 AG054126NIA NIH HHS R01 AG056770NIGMS NIH HHS R25 GM056847NINDS NIH HHS K08 NS114170Programa de Apoyo a Centros con Financiamiento Basal AFB 170004
6 · The paper itself

Abstract

With increased life expectancy, age-associated cognitive decline becomes a growing concern, even in the absence of recognizable neurodegenerative disease. The integrated stress response (ISR) is activated during aging and contributes to age-related brain phenotypes. We demonstrate that treatment with the drug-like small-molecule ISR inhibitor ISRIB reverses ISR activation in the brain, as indicated by decreased levels of activating transcription factor 4 (ATF4) and phosphorylated eukaryotic translation initiation factor eIF2. Furthermore, ISRIB treatment reverses spatial memory deficits and ameliorates working memory in old mice. At the cellular level in the hippocampus, ISR inhibition (i) rescues intrinsic neuronal electrophysiological properties, (ii) restores spine density and (iii) reduces immune profiles, specifically interferon and T cell-mediated responses. Thus, pharmacological interference with the ISR emerges as a promising intervention strategy for combating age-related cognitive decline in otherwise healthy individuals.

Indexed as

AcetamidesActivating Transcription Factor 4AgingAnimalsBrainCognitive DysfunctionCyclohexylaminesDendritic SpinesFemaleHippocampusMaleMemoryMiceMice, Inbred C57BLNeuronsNootropic Agents2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamideAcetamidesActivating Transcription Factor 4Atf4 protein, mouseCyclohexylaminesNootropic Agentsagingimmune dysfunctionISRmemorymouseneuroscience

Identifiers

PMID33258451
PMCPMC7721440
OpenAlexW3110019071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.